- Home
- / Pharma Research Products
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Pharma Research Products financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
₩536.3 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| KRW | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 64.3B | 83.9B | 108.7B | 154.1B | 194.8B | 261.0B | 350.1B | 536.3B |
| Cost of goods sold | 22.4B | 26.1B | 25.4B | 33.6B | 50.5B | 66.8B | 94.2B | 119.3B |
| Gross profit | 49.3B | 58.6B | 88.8B | 122.0B | 145.6B | 199.7B | 258.9B | 417.5B |
| Gross profit margin, % | 69.9% | 81.7% | 79.2% | 74.7% | 76.5% | 74.0% | 77.8% | |
| Operating expense total | 28.1B | 31.1B | 41.5B | 58.4B | 72.6B | 90.0B | 116.2B | 186.8B |
| Depreciation and amortization | 6.1B | 7.7B | 9.6B | 10.4B | 10.7B | 15.1B | 13.6B | 17.2B |
| EBITDA | 20.3B | 26.6B | 50.4B | 64.3B | 70.1B | 110.4B | 148.7B | 228.2B |
| EBITDA margin, % | 31.7% | 46.4% | 41.7% | 36.0% | 42.3% | 42.5% | 42.5% | |
| EBIT | 12.6B | 17.8B | 39.4B | 53.2B | 55.9B | 92.4B | 110.9B | 207.5B |
| EBIT margin, % | 21.2% | 36.3% | 34.6% | 28.7% | 35.4% | 31.7% | 38.7% | |
| Interest income | 2.5B | 2.2B | 2.1B | 3.7B | 5.3B | 7.4B | 10.2B | 30.1B |
| Interest expense | 803.6M | 2.3B | 1.8B | 1.3B | 3.8B | 3.0B | 4.6B | 20.9B |
| Pre tax profit | 14.4B | 18.5B | 39.5B | 56.0B | 54.0B | 100.7B | 115.8B | 216.5B |
| Income tax expense | 3.1B | 3.7B | 7.1B | 9.2B | 10.6B | 23.4B | 26.9B | 48.3B |
| Net Income | 11.3B | 14.9B | 32.5B | 46.8B | 43.4B | 77.3B | 88.9B | 168.3B |